Showing 3971-3980 of 10626 results for "".
Roflumilast Foam for Psoriasis: Efficacy, Tolerability, and Clinical Relevance
https://reachmd.com/programs/dermconsult/roflumilast-foam-for-psoriasis-efficacy-tolerability-and-clinical-relevance/36370/Early Initiation of Acoramidis in ATTR-CM: Importance and Long-Term Impacts
https://reachmd.com/programs/heart-matters/early-initiation-of-acoramidis-in-attr-cm-importance-and-long-term-impacts/35757/Acoramidis, a treatment for transthyretin amyloid cardiomyopathy (ATTR-CM), was studied in an open-label extension of the ATTRibute-CM trial to determine whether its early and sustained use improves clinical outcomes. Discover acoramidis’ long-term impacts on all-cause mortality and/or first cardiovCAR T-Cell Therapy: New Frontiers in Diffuse Systemic Sclerosis Treatment
https://reachmd.com/programs/living-rheum/car-t-cell-therapy-new-frontiers-in-diffuse-systemic-sclerosis-treatment/30073/CD19-targeted CAR T-cell therapy may offer lasting benefits for diffuse systemic sclerosis. Here’s what you should know.Make a Statement
https://reachmd.com/topics/practice-development/make-a-statement/35214/Tips and inspiration for writing your brand’s mission, vision, and core values statementsReal Techniques to Promote Diversity and Inclusivity at Your Practice
https://reachmd.com/ma-issues-index/2022-may-june/real-techniques-to-promote-diversity-and-inclusivity-at-your-practice/35168/Addressing diversity requires more than being aware of observable differencesA Look at Emerging Virtual Reality Tools in Gastroenterology
https://reachmd.com/programs/gi-insights/a-look-at-emerging-virtual-reality-tools-in-gastroenterology/13732/How can technology make us better clinicians? Here are the latest artificial intelligence and virtual reality advances in gastroenterology.Beauty Counter MD
https://reachmd.com/topics/skincare/beauty-counter-md-16/35144/Expert insight on the hottest products, ingredients, and trends your patients are talking aboutRenin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19
https://reachmd.com/programs/the-drug-report/renin-angiotensin-aldosterone-system-inhibitors-in-patients-with-covid-19/11416/Do the benefits of continuing the use of RAAS inhibitors in patients outweigh the risks due to the inhibitors’ potential link to COVID-19 severity?Historian John Barry on COVID-19
https://reachmd.com/programs/public-health-call/historian-john-barry-on-covid-19/11430/The historical context of 1918 shaped much of the response to the flu pandemic in the US—just as it will with COVID-19 today.Weekly Check-up | September 5th 2016
https://reachmd.com/programs/the-weekly-check-up/weekly-check-september-5th-2016/8334/Welcome to the Weekly Check-up on ReachMD for the week of September 5th, 2016.